Press Releases

Two blocks of colored pixels. Each pixel represents a mouse behavior or “syllable” and each row shows the behavior pattern of one mouse. The bottom block shows the behavior patterns of mice with epilepsy compared to controls, above.
By using state-of-the-art technology to analyze patterns of behavior in mice with epilepsy, researchers may be able to better study the disorder and identify potential treatments.
Friday, February 24, 2023
Illustration of the cervical spinal cord.
In a small study, researchers used a device that stimulates the spinal cord to restore arm and hand mobility in two stroke patients, allowing them to perform daily life activities, such as using a fork to eat a meal.
Monday, February 20, 2023
Masked doctor speaks with older masked patient
Black and Hispanic Americans appear to experience more symptoms and health problems related to long COVID, a lay term that captures an array of symptoms and health problems, than white people, but are not as likely to be diagnosed with the condition, according to new research funded by the National Institutes of Health.
Thursday, February 16, 2023
3D illustration of human gut bacteria.
Researchers have found differences in the gut microbiomes of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy controls.
Wednesday, February 8, 2023
Cell types found in the spinal cord
Human spinal cord cell atlas provides foundation to study neurodegeneration, chronic pain, and other diseases.
Thursday, February 2, 2023
photo of Dr. Ralph L. Sacco
NINDS is mourning the death of Dr. Ralph Sacco, renowned stroke neurologist who enriched NINDS as a grantee, mentor, and member of the NINDS Advisory Council. Dr. Sacco passed away on January 17, 2023, due to a brain tumor. He was 65.
Friday, January 20, 2023
Green neurons in a mouse brain.
Using a mouse model, researchers have discovered a new daily rhythm in a type of synapse that dampens brain activity.
Tuesday, November 1, 2022
Today, the U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND)—a public-private partnership aimed at advancing the understanding of neurodegenerative diseases and fostering the development of treatments for amyotrophic lateral sclerosis (ALS) and other rare neurodegenerative diseases.
Wednesday, September 14, 2022
Researchers have published two papers describing how they identified a potential new pathway for treating a sporadic form of amyotrophic lateral sclerosis (ALS). The studies were published as part of a cooperative research agreement between the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and the Switzerland-based biotechnology company GeNeuro Inc.
Tuesday, August 30, 2022
Multiple MRI images of the brain
A study funded by the National Institutes of Health found that biomarkers present in the blood on the day of a traumatic brain injury (TBI) can accurately predict a patient’s risk of death or severe disability six months later. Measuring these biomarkers may enable a more accurate assessment of patient prognosis following TBI, according to results published today in Lancet Neurology. 
Wednesday, August 10, 2022